We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Industry

Image: Tempus becomes the second commercial laboratory partner in CellCarta’s CDx Commercialization Lab Network, contributing its oncology expertise to the company’s CDx Accelerator Model

Strategic Collaboration Expands Commercial Access to Oncology Companion Diagnostics

CellCarta announced a strategic collaboration with Tempus AI to broaden access to companion diagnostics (CDx) in oncology. More...
18 Aug 2026
Image: The collaboration shows how AI-powered Tissue Intelligence can standardize biomarker analysis and link tissue biology to clinical outcomes for translational research and precision medicine.

Collaboration Supports Global ADC Development with AI-Powered Tissue Analysis

Nucleai announced an ongoing translational research collaboration with Gilead Sciences to support global ADC development programs. More...
13 Aug 2026
Image: The SuperFlex prenatal screening system brings rapid, decentralized biochemistry‑based prenatal screening into small and mid‑sized laboratories (Photo courtesy of Revvity)

Compact Prenatal Screening System Expands Access to Preeclampsia Testing

Revvity has introduced SuperFlex, a compact CE-IVDR certified immunoassay system for maternal and fetal biochemistry testing in lower-volume workflows. More...
12 Aug 2026
Image: Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS Trust with a pathology slide showing the TANGO technology (Photo courtesy of Leeds Teaching Hospitals NHS Trust)

Standardized Staining Technology Advances Digital Pathology Workflows

A new quality-control slide system standardizes pathology staining, reducing variability to speed AI-enabled cancer diagnostics. More...
07 Aug 2026
Image: The dPCR assay targets the most common KMT2A partner fusion genes found in AML and ALL, aligning with the disease biology relevant to current menin inhibitor programs (Image Credit: Shutterstock)

Global Testing Service Advances Leukemia MRD Monitoring

A new digital PCR test measures residual disease markers in acute leukemias with high sensitivity. More...
06 Aug 2026
Image: Medicare coverage for NeXT Personal now spans four indications (Photo courtesy of Personalis)

Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

Personalis’ NeXT Personal received expanded Medicare coverage for immuno-oncology and neoadjuvant breast cancer monitoring. More...
06 Aug 2026
Image Credit: iStock

Genprex and Roche Collaborate on AI-Driven NSCLC Biomarker Testing

An AI-driven biomarker scoring test aims to refine lung cancer patient selection and speed clinical trial enrollment. More...
05 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
HPV Test
Allplex HPV28 Detection


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.